NO974911D0 - Fremstilling og anvendelse av sulfaterte oligosakarider - Google Patents

Fremstilling og anvendelse av sulfaterte oligosakarider

Info

Publication number: NO974911D0
Authority: NO; Norway
Prior art keywords: pct; preparation; date oct; sec; sulfated oligosaccharides
Prior art date: 1995-04-28

Application number

NO974911A

Other languages

English (en)

Other versions

NO974911L (no

Inventor

Christopher Richard Parish

William Butler Cowden

Original Assignee

Univ Australian

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1995-04-28

Filing date

1997-10-24

Publication date

1997-10-24

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=3786969&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO974911(D0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

1997-10-24 Application filed by Univ Australian filed Critical Univ Australian

1997-10-24 Publication of NO974911D0 publication Critical patent/NO974911D0/no

1997-12-29 Publication of NO974911L publication Critical patent/NO974911L/no

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/702—Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/716—Glucans
- A61K31/722—Chitin, chitosan
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H11/00—Compounds containing saccharide radicals esterified by inorganic acids; Metal salts thereof
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H3/00—Compounds containing only hydrogen atoms and saccharide radicals having only carbon, hydrogen, and oxygen atoms
- C07H3/06—Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
- C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
- C08B37/0006—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid
- C08B37/0024—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid beta-D-Glucans; (beta-1,3)-D-Glucans, e.g. paramylon, coriolan, sclerotan, pachyman, callose, scleroglucan, schizophyllan, laminaran, lentinan or curdlan; (beta-1,6)-D-Glucans, e.g. pustulan; (beta-1,4)-D-Glucans; (beta-1,3)(beta-1,4)-D-Glucans, e.g. lichenan; Derivatives thereof
- C08B37/0027—2-Acetamido-2-deoxy-beta-glucans; Derivatives thereof
- C08B37/003—Chitin, i.e. 2-acetamido-2-deoxy-(beta-1,4)-D-glucan or N-acetyl-beta-1,4-D-glucosamine; Chitosan, i.e. deacetylated product of chitin or (beta-1,4)-D-glucosamine; Derivatives thereof

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
Organic Chemistry (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Animal Behavior & Ethology (AREA)
Engineering & Computer Science (AREA)
Chemical Kinetics & Catalysis (AREA)
Bioinformatics & Cheminformatics (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Molecular Biology (AREA)
Epidemiology (AREA)
Biochemistry (AREA)
Genetics & Genomics (AREA)
Biotechnology (AREA)
Neurosurgery (AREA)
Biomedical Technology (AREA)
Neurology (AREA)
Diabetes (AREA)
Immunology (AREA)
Pulmonology (AREA)
Cardiology (AREA)
Polymers & Plastics (AREA)
Materials Engineering (AREA)
Heart & Thoracic Surgery (AREA)
Endocrinology (AREA)
Obesity (AREA)
Psychiatry (AREA)
Pain & Pain Management (AREA)
Rheumatology (AREA)
Ophthalmology & Optometry (AREA)
Physical Education & Sports Medicine (AREA)
Oncology (AREA)
Transplantation (AREA)
Hospice & Palliative Care (AREA)

NO974911A 1995-04-28 1997-10-24 Fremstilling og anvendelse av sulfaterte oligosakarider NO974911L (no)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
AUPN2618A AUPN261895A0 (en)	1995-04-28	1995-04-28	Preparation and use of sulfated oligosaccharides
PCT/AU1996/000238 WO1996033726A1 (en)	1995-04-28	1996-04-24	Preparation and use of sulfated oligosaccharides

Publications (2)

Publication Number	Publication Date
NO974911D0 true NO974911D0 (no)	1997-10-24
NO974911L NO974911L (no)	1997-12-29

Family

ID=3786969

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO974911A NO974911L (no)	1995-04-28	1997-10-24	Fremstilling og anvendelse av sulfaterte oligosakarider

Country Status (26)

Country	Link
US (1)	US6143730A (no)
EP (1)	EP0837683B1 (no)
JP (2)	JP4514240B2 (no)
KR (1)	KR100591960B1 (no)
CN (1)	CN1090021C (no)
AT (1)	ATE463250T1 (no)
AU (1)	AUPN261895A0 (no)
BR (1)	BR9608041B8 (no)
CA (1)	CA2218872C (no)
CZ (1)	CZ341097A3 (no)
DE (1)	DE69638158D1 (no)
EA (1)	EA001199B1 (no)
EE (1)	EE9700277A (no)
ES (1)	ES2341924T3 (no)
FI (1)	FI974060L (no)
HU (1)	HUP9802394A2 (no)
IL (1)	IL118047A (no)
IS (1)	IS4596A (no)
NO (1)	NO974911L (no)
NZ (1)	NZ305815A (no)
PL (1)	PL184357B1 (no)
PT (1)	PT837683E (no)
TR (1)	TR199701264T1 (no)
TW (1)	TW446710B (no)
WO (1)	WO1996033726A1 (no)
ZA (1)	ZA963339B (no)

Families Citing this family (67)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
AUPO556297A0 (en) *	1997-03-11	1997-04-10	Australian National University, The	Sulfated oligosaccharides having anticoagulant/ antithrombotic activity
DK1014996T3 (da) *	1997-08-28	2003-09-29	Univ Washington	Præparater indeholdende saccharid til behandling af Alzheimers sygdom og andre amyloidoser
AUPO888497A0 (en) *	1997-09-01	1997-09-25	Australian National University, The	Use of sulfated oligosaccharides as inhibitors of cardiovascular disease
AUPO976897A0 (en) *	1997-10-14	1997-11-06	Australian National University, The	Use of sulfated oligosaccharides in lowering blood triglyceride levels
GB9802725D0 (en)	1998-02-09	1998-04-08	Ciba Geigy Ag	Organic compounds
US7132402B2 (en) *	1998-11-24	2006-11-07	Wyeth	Acylated benzylmaltosides as inhibitors of smooth muscle cell proliferation
US7081448B2 (en) *	1998-11-24	2006-07-25	Wyeth	Benzyllactobionamides as inhibitors of smooth muscle cell proliferation
US20040220103A1 (en) *	1999-04-19	2004-11-04	Immunex Corporation	Soluble tumor necrosis factor receptor treatment of medical disorders
US6083933A (en) *	1999-04-19	2000-07-04	Stellar International Inc.	Treatment of cystitis-like symptoms with chondroitin sulfate following administration of a challenge solution
GB0001481D0 (en) *	2000-01-21	2000-03-15	Theryte Ltd	System for delivering a medicament
GB0003048D0 (en) *	2000-02-11	2000-03-29	Dealler Stephen F	The therapeutic use of polysulphonated polyglycosides or other polyanionic compounds in autism
FR2808687B1 (fr) *	2000-04-27	2003-12-05	Goemar Lab Sa	Medicament contenant des substances polysaccharidiques pour l'activation de l'apoptose
JP4676048B2 (ja) *	2000-07-10	2011-04-27	生化学工業株式会社	脱髄性疾患処置剤
US7407773B2 (en) *	2000-11-03	2008-08-05	Procognia, Ltd.	Method for characterizing a carbohydrate polymer
TW519716B (en) *	2000-12-19	2003-02-01	Tokyo Electron Ltd	Wafer bias drive for a plasma source
CA2435637A1 (en) *	2001-01-23	2002-08-01	Massachusetts Institute Of Technology	Solid- and solution -phase synthesis of heparin and other glycosaminoglycans
CN1394867A (zh) *	2001-07-06	2003-02-05	中国科学院生态环境研究中心	可作药物的寡糖和其制备方法及含该寡糖的药物组合物
SK288335B6 (sk)	2001-09-12	2016-02-02	Sigma-Tau Research Switzerland S.A.	Čiastočne alebo úplne N-desulfatovaný, N-reacetylovaný heparín, spôsob jeho prípravy, jeho použitie na prípravu liečiva s inhibičným účinkom na heparanázu, s antiangiogénnym a protizápalovým účinkom a farmaceutický prostriedok s jeho obsahom
KR20030046810A (ko) *	2001-12-06	2003-06-18	은삼제약 주식회사	콘드로이친 황산의 분해산물을 포함하는 관절염 예방 또는치료용 약학적 조성물
AUPS052802A0 (en) *	2002-02-15	2002-03-07	Praxis Pharmaceuticals International Pty Ltd	Carbohydrate-based anti-wrinkle and tissue remodelling compounds
AU2003225724A1 (en) *	2002-03-11	2003-09-29	Momenta Pharmaceuticals, Inc.	Analysis of sulfated polysaccharides
US20040161476A1 (en)	2003-02-19	2004-08-19	Hahn Sungtack Samuel	Cystitis treatment with high dose chondroitin sulfate
WO2005054493A2 (en) *	2003-06-12	2005-06-16	Mayo Foundation For Medical Education And Research	Altered activity of toll-like receptors
CN104119404A (zh) *	2004-03-04	2014-10-29	普罗吉恩制药有限公司	硫酸化寡聚糖衍生物
AU2007312880A1 (en) *	2006-10-20	2008-04-24	The Australian National University	Inhibition of degradation of extracellular matrix
US9139876B1 (en)	2007-05-03	2015-09-22	Momenta Pharmacueticals, Inc.	Method of analyzing a preparation of a low molecular weight heparin
EP2164501B1 (en) *	2007-05-31	2016-04-20	Paradigm Biopharmaceuticals Limited	Sulphated xylans for treatment or prophylaxis of respiratory diseases
EP2604254B1 (en) *	2007-06-28	2016-12-21	BASF Beauty Care Solutions France SAS	Slimming composition
US8153611B2 (en) *	2007-06-28	2012-04-10	Basf Beauty Care Solutions France S.A.S.	Use of sulfated oligosaccharides as slimming cosmetic ingredients
FR2917971B1 (fr)	2007-06-28	2009-10-23	Engelhard Lyon Soc Par Actions	Composition amincissante
WO2009049370A1 (en) *	2007-10-16	2009-04-23	Progen Pharmaceuticals Limited	Novel sulfated oligosaccharide derivatives
WO2009078015A2 (en) *	2007-12-18	2009-06-25	Procognia (Israel) Ltd	Method and assay for glycosylation pattern detection related to cell state of stem cells
JP2011522805A (ja) *	2008-05-30	2011-08-04	モメンタファーマシューティカルズインコーポレイテッド	糖構造ならびにそのような構造を作製および使用する方法
EP2149580A1 (en)	2008-07-15	2010-02-03	Istituto Scientifico di Chimica E Biochimica "G Ronzoni	Mimetics of sulfated oligosaccharides
US8592140B2 (en)	2009-01-02	2013-11-26	Biomarin Pharmaceutical Inc.	Detection of oligosaccharides
US8232073B2 (en)	2009-01-02	2012-07-31	Zacharon Pharmaceuticals, Inc.	Quantification of non-reducing end glycan residual compounds
US8809009B2 (en)	2009-01-02	2014-08-19	Biomarin Pharmaceutical Inc.	Methods of diagnosing a disease and methods of monitoring treatment of a disease by quantifying a non-reducing end glycan residual compound and comparing to a second biomarker
US9029530B2 (en)	2009-01-02	2015-05-12	Biomarin Pharmaceutical Inc.	Detection of oligosaccharides
GB0915315D0 (en) *	2009-09-03	2009-10-07	Univ Manchester	Use of non-digestible oligosaccharides
JP5701498B2 (ja) *	2009-12-01	2015-04-15	公益財団法人微生物化学研究会	炎症性細胞からのヘパラナーゼの放出抑制剤、抗炎症剤、及び薬用組成物
EP2526122B1 (en) *	2010-01-19	2020-06-10	Momenta Pharmaceuticals, Inc.	Evaluating heparin preparations
JPWO2011122321A1 (ja) *	2010-03-29	2013-07-08	国立大学法人名古屋大学	ヘパリン結合性蛋白に対する生理活性阻害剤
HUE043546T2 (hu) *	2010-12-01	2019-08-28	Univ Australian National	Polianionok alkalmazása hisztonok citotoxikus aktivitásának gátlására szepszis kezelésében
EP2675895A4 (en) *	2011-02-18	2014-07-30	Harvard College	MOLECULAR SWITCH FOR NEURONAL GROWTH
US9068957B2 (en)	2011-02-21	2015-06-30	Momenta Pharmaceuticals, Inc.	Evaluating heparin preparations
CN102199175A (zh) *	2011-04-07	2011-09-28	福州大学	硫酸类肝素二糖的制备纯化方法及其纯化产品
CN107362168A (zh) *	2011-06-09	2017-11-21	基亚生物科技股份有限公司	用于抑制肝癌复发、恶化或转移之医药组成物
AU2013215237B2 (en) *	2012-01-30	2017-11-23	Baxalta GmbH	Non-anticoagulant sulfated or sulfonated polysaccharides
BR112015028710A2 (pt) *	2013-05-16	2017-09-19	Agency Science Tech & Res	Sulfato de heparan hs8 isolado ou substancialmente purificado, composição farmacêutica ou medicamento, implante biocompatível ou prótese, método de formação de um implante ou prótese biocompatível, método de cultivo de células-tronco, método de enriquecimento para unidades formadoras de colônias, meio de cultura, kit de peças, produtos e método para aumentar a estabilidade de um fator de crescimento
JP2017515898A (ja)	2014-05-08	2017-06-15	イミューンエクサイト，インコーポレイテッド	免疫調節β−１，６−Ｄ−グルカン
SE538503C2 (en)	2014-11-11	2016-08-16	Tx Medic Ab	New dextran sulfate
CZ306662B6 (cs) *	2015-06-26	2017-04-26	Contipro A.S.	Deriváty sulfatovaných polysacharidů, způsob jejich přípravy, způsob jejich modifikace a použití
CN105504097B (zh) *	2015-12-30	2018-07-03	深圳市海普瑞药业集团股份有限公司	一种硫酸化肝素寡糖及其制备方法和应用
JP2016199579A (ja) *	2016-07-08	2016-12-01	基亜生物科技股▲ふん▼有限公司ＭｅｄｉｇｅｎＢｉｏｔｅｃｈｎｏｌｏｇｙＣｏｒｐ．	肝癌の再発、悪化または転移の抑制に用いる医薬組成物
US11787783B2 (en)	2016-12-13	2023-10-17	Beta Therapeutics Pty Ltd	Heparanase inhibitors and use thereof
RU2019121873A (ru)	2016-12-13	2021-01-15	БЕТА ТЕРАПЬЮТИКС ПиТиУай ЛТД	Ингибиторы гепараназы и их применение
US11141428B2 (en) *	2017-12-12	2021-10-12	Academia Sinica	Octasaccharides and uses thereof
WO2019113646A1 (en) *	2017-12-15	2019-06-20	Griffith University	Sulfation method
JP6619830B2 (ja) *	2018-02-22	2019-12-11	基亜生物科技股▲ふん▼有限公司ＭｅｄｉｇｅｎＢｉｏｔｅｃｈｎｏｌｏｇｙＣｏｒｐ．	肝癌の再発、悪化または転移の抑制に用いる医薬組成物
NL2024493B1 (en) *	2019-12-16	2021-09-02	Logick Energetics B V	Pharmaceutical composition for preventing or stopping metastases
US20230023285A1 (en)	2019-12-18	2023-01-26	Logick Energetics B.V.	Pharmaceutical composition for use in preventing or stopping metastases
CN110917208B (zh) *	2019-12-27	2021-02-12	浙江医院	硫酸化甘露葡萄糖醛酸六糖在防治动脉粥样硬化中的应用
CN111904968A (zh) *	2020-08-21	2020-11-10	青岛市中心医院	硫酸半乳四糖及其衍生物在制备抗上皮细胞黏附药物中的应用
CN113633658A (zh) *	2021-07-09	2021-11-12	南京理工大学	硫酸葡半乳寡聚糖在制备抗凝血和/或抗血栓药物中的应用
CN114134188B (zh) *	2021-07-23	2023-03-17	光明乳业股份有限公司	一种发酵小麦麸皮合成胞外多糖的方法
CN115646378A (zh) *	2022-09-15	2023-01-31	哈尔滨工业大学	一种生物质胶质凝胶及其制备方法、应用
CN116650425B (zh) *	2023-07-13	2025-06-27	晟迪生物医药(苏州)有限公司	糖酯化合物或其盐在冷冻保护、冷冻干燥保护中的应用

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
ZA869530B (en) *	1985-12-24	1987-10-28	Marion Laboratories Inc	Use of synthetic sulfated saccharides to enhance wound healing
FR2597484B1 (fr) *	1986-04-17	1988-12-23	Sanofi Sa	Glycosaminoglycanes de type heparine ou heparane-sulfate dotes d'une activite sur la division et la differentiation cellulaires, leur preparation et leurs applications therapeutiques.
US5541166A (en) *	1987-01-23	1996-07-30	The Australian National University	Sulphated polysaccharides having anti-metastatic and/or anti-inflammatory activity
WO1989003684A1 (fr) *	1987-10-30	1989-05-05	Chugai Seiyaku Kabushiki Kaisha	Agent anti-vih
US5506210A (en) *	1988-08-19	1996-04-09	The Australian National University	Phosphosugar-based anti-inflammatory and/or immunosuppressive drugs
JPH0296588A (ja) *	1988-09-29	1990-04-09	Rikagaku Kenkyusho	硫酸化オリゴ糖及びその関連物質
JP2956090B2 (ja) *	1989-10-30	1999-10-04	大日本インキ化学工業株式会社	オリゴ糖誘導体
WO1992003453A1 (en) *	1990-08-23	1992-03-05	Dainippon Ink & Chemicals, Inc.	Antiviral agent
CA2061370A1 (en) *	1991-03-13	1992-09-14	Markus Hosang	Pharmaceutical preparations
WO1992018546A1 (en) *	1991-04-17	1992-10-29	Glycomed, Inc.	Sulfated polysaccharides as inhibitors of smooth muscle cell proliferation
JPH06256373A (ja) *	1993-01-11	1994-09-13	Dainippon Ink & Chem Inc	硫酸化オリゴ糖配糖体アシル化物およびこれを有効成分とする抗ウイルス剤
US5459257A (en) *	1993-01-11	1995-10-17	Dainippon Ink And Chemicals, Inc.	Sulfated oligoglycoside acylate and antiviral agent containing the same as active ingredient
FR2710741B1 (fr) *	1993-09-30	1995-10-27	Commissariat Energie Atomique	Capteur électronique destiné à la caractérisation de grandeurs physiques et procédé de réalisation d'un tel capteur.
US5739115A (en) *	1993-10-07	1998-04-14	Glycomed Incorporated	Sulfated maltooligosaccharides with heparin-like properties
CA2171465A1 (en) *	1993-10-07	1995-04-13	Peter Fugedi	Highly sulfated maltooligosaccharides with heparin-like properties

1995
- 1995-04-28 AU AUPN2618A patent/AUPN261895A0/en not_active Abandoned
1996
- 1996-04-24 WO PCT/AU1996/000238 patent/WO1996033726A1/en not_active Ceased
- 1996-04-24 ES ES96910861T patent/ES2341924T3/es not_active Expired - Lifetime
- 1996-04-24 BR BRPI9608041-8B8A patent/BR9608041B8/pt not_active IP Right Cessation
- 1996-04-24 PT PT96910861T patent/PT837683E/pt unknown
- 1996-04-24 CA CA002218872A patent/CA2218872C/en not_active Expired - Lifetime
- 1996-04-24 FI FI974060A patent/FI974060L/fi unknown
- 1996-04-24 HU HU9802394A patent/HUP9802394A2/hu unknown
- 1996-04-24 US US08/945,937 patent/US6143730A/en not_active Expired - Lifetime
- 1996-04-24 EA EA199700347A patent/EA001199B1/ru not_active IP Right Cessation
- 1996-04-24 EE EE9700277A patent/EE9700277A/xx unknown
- 1996-04-24 JP JP53203896A patent/JP4514240B2/ja not_active Expired - Lifetime
- 1996-04-24 CZ CZ973410A patent/CZ341097A3/cs unknown
- 1996-04-24 CN CN96193563A patent/CN1090021C/zh not_active Expired - Lifetime
- 1996-04-24 KR KR1019970707723A patent/KR100591960B1/ko not_active Expired - Lifetime
- 1996-04-24 PL PL96323080A patent/PL184357B1/pl unknown
- 1996-04-24 NZ NZ305815A patent/NZ305815A/xx not_active IP Right Cessation
- 1996-04-24 AT AT96910861T patent/ATE463250T1/de not_active IP Right Cessation
- 1996-04-24 DE DE69638158T patent/DE69638158D1/de not_active Expired - Lifetime
- 1996-04-24 EP EP96910861A patent/EP0837683B1/en not_active Expired - Lifetime
- 1996-04-24 TR TR97/01264T patent/TR199701264T1/xx unknown
- 1996-04-25 TW TW085104940A patent/TW446710B/zh not_active IP Right Cessation
- 1996-04-26 IL IL11804796A patent/IL118047A/xx not_active IP Right Cessation
- 1996-04-26 ZA ZA963339A patent/ZA963339B/xx unknown
1997
- 1997-10-21 IS IS4596A patent/IS4596A/is unknown
- 1997-10-24 NO NO974911A patent/NO974911L/no not_active Application Discontinuation
2009
- 2009-06-09 JP JP2009138310A patent/JP2009235085A/ja not_active Withdrawn

Also Published As

Publication number	Publication date
JPH11504018A (ja)	1999-04-06
CA2218872C (en)	2007-02-20
ATE463250T1 (de)	2010-04-15
CA2218872A1 (en)	1996-10-31
FI974060A7 (fi)	1997-10-27
IL118047A0 (en)	1996-08-04
EA001199B1 (ru)	2000-12-25
EE9700277A (et)	1998-04-15
BR9608041B1 (pt)	2012-02-22
HUP9802394A2 (hu)	1999-02-01
EP0837683A4 (en)	2007-07-04
TR199701264T1 (xx)	1998-02-21
KR19990008198A (ko)	1999-01-25
JP2009235085A (ja)	2009-10-15
CN1183043A (zh)	1998-05-27
BR9608041A (pt)	1999-01-26
PT837683E (pt)	2010-07-09
MX9708289A (es)	1998-06-30
PL184357B1 (pl)	2002-10-31
BR9608041B8 (pt)	2014-11-18
WO1996033726A1 (en)	1996-10-31
JP4514240B2 (ja)	2010-07-28
KR100591960B1 (ko)	2007-12-04
NO974911L (no)	1997-12-29
IL118047A (en)	2000-11-21
AUPN261895A0 (en)	1995-05-18
IS4596A (is)	1997-10-21
CN1090021C (zh)	2002-09-04
CZ341097A3 (cs)	1998-03-18
NZ305815A (en)	1999-05-28
US6143730A (en)	2000-11-07
ZA963339B (en)	1997-01-03
EP0837683A1 (en)	1998-04-29
TW446710B (en)	2001-07-21
ES2341924T3 (es)	2010-06-29
FI974060A0 (fi)	1997-10-27
FI974060L (fi)	1997-10-27
EA199700347A1 (ru)	1998-06-25
DE69638158D1 (de)	2010-05-20
EP0837683B1 (en)	2010-04-07
PL323080A1 (en)	1998-03-02

Publication	Publication Date	Title
NO974911D0 (no)	1997-10-24	Fremstilling og anvendelse av sulfaterte oligosakarider
DK0696297T3 (da)	1999-05-10	Pyridobisimidazolbaseret stiv stavpolymer
ATE326862T1 (de)	2006-06-15	Oligosaccharide enthaltende ernährungszusammensetzungen
BG103485A (en)	2000-01-31	Ketobanzamides as calpain inhibitors
ATE409048T1 (de)	2008-10-15	Pharmazeutisch aktive oligosaccharid-conjugate
AUPP268898A0 (en)	1998-04-23	High modulus polyurethane compositions
NO20006323D0 (no)	2000-12-12	Glykopeptidderivater og farmasöytiske sammensetninger som inneholder disse
NO990497L (no)	1999-03-24	Modifiserte oligosakkarider
GB9902555D0 (en)	1999-03-24	Medicament
WO2003055444A3 (en)	2003-09-18	Resveratrol analogues
HU9301518D0 (en)	1993-09-28	Medical preparatives
ATE388960T1 (de)	2008-03-15	Glykopeptidderivate mit carboxysacchariden
PT96849A (pt)	1991-10-31	Processo de preparacao de novos derivados da beta-fenil-iso-serina e de beta-fenil-iso-serina-(2r,2s)
NO971318L (no)	1997-08-11	Jodiserte röntgenkontrastmidler
FR2812637B1 (fr)	2002-10-25	Nouveaux composes derives de dihydroporphyrine et leurs applications
DE59803066D1 (de)	2002-03-21	Substituierte benzyloxyimino-verbindungen
MX9302272A (es)	1993-10-01	Retinoides solubles en agua.
DK0713485T3 (da)	1998-12-07	Thiocarbamoylforbindelser som mikrobicider
GR1001216B (el)	1993-06-21	Συνθεση ιξωδοελαστικου υδατικου υγρου απορρυπαντικου, ειδικα για αυτοματα πλυντηρια πιατων, βελτιωμενης ικανοτητας διανομης.
DE69111119D1 (de)	1995-08-17	Durch Fermentation hergestellte Polysaccharide.
MX9704744A (es)	1997-10-31	Derivados de alquilpolisacarido y composiciones.
KR930005623A (ko)	1993-04-20	복합 올리고당 조성물

Legal Events

Date	Code	Title	Description
2001-02-05	FC2A	Withdrawal, rejection or dismissal of laid open patent application